Divya Ramnath

Dr. Divya Ramnath is a Research Fellow at the Institute for Molecular Bioscience (IMB), The University of Queensland, working in Prof. Matt Sweet's laboratory at the IMB Centre for Inflammation and Disease Research (CIDR). As an early career post-doctoral researcher, she leads projects characterizing inflammation-associated determinants of chronic liver disease.

Her research focuses on the intersection of immunology, inflammation, and liver disease, with particular expertise in macrophage biology, immunometabolism, and epigenetic regulation. Dr. Ramnath's work has significantly advanced understanding of how histone deacetylases, particularly HDAC7, regulate immune responses, mitochondrial dynamics, and metabolic pathways in inflammatory conditions.

Analysis of her publication record reveals a strong trajectory in immunometabolism research, with increasing focus on the role of epigenetic regulators in macrophage function and liver disease pathogenesis. Her recent work demonstrates how histone deacetylases serve as critical signaling hubs that integrate metabolic and inflammatory pathways, with implications for therapeutic interventions in chronic inflammatory diseases.

Dr. Ramnath is actively involved in research supervision, serving as Associate Advisor for PhD students working on projects related to innate immune defense against bacterial infections. She has secured competitive funding including the Cure4CF Foundation Research Grant (2025-2026) for her project 'Think ZINC: Zinc immune-related Needs in Cystic fibrosis' and previously received NHMRC IDEAS Grant funding (2020-2023) for research on 'Defining molecular links between immune cell metabolism and inflammation'.

Her laboratory work is centered at the IMB Centre for Inflammation and Disease Research, where she collaborates with leading researchers including Prof. Matt Sweet, Prof. David Fairlie, and Prof. Mark Schembri. Dr. Ramnath's research program integrates molecular, cellular, and translational approaches to understand and develop interventions for inflammatory liver diseases.